Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles

Retrovirology

Volumn 11, Issue 1, 2014, Pages

  Gregory, Devon A ^a   Olinger, Grace Y ^b   Lucas, Tiffany M ^c   Johnson, Marc C ^a  

^a University of Missouri   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Assembly; CD4; Ebola GP; Env; Glycoprotein recruitment; Pseudotype; VSV G

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SCANNING ELECTRON MICROSCOPY; VIRION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RELEASE;

EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS; ROUS SARCOMA VIRUS; VESICULAR STOMATITIS VIRUS;

ANTIGENS, CD4; CELL LINE; GLYCOPROTEINS; HIV-1; HUMANS; VIRAL PROTEINS; VIRUS ASSEMBLY;

EID: 84898024903     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-11-28     Document Type: Article

References (50)

1. Zavada J. The pseudotypic paradox. J Gen Virol 1982, 63(Pt 1):15-24.
2. Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005, 5:387-398. 10.2174/1566523054546224, 1368960, 16101513.
3. Granoff A, Hirst GK. Experimental production of combination forms of virus. IV. Mixed influenza A-Newcastle disease virus infections. Proc Soc Exper BiolMed (New York, NY) 1954, 86:84-88.
4. Jorgenson RL, Vogt VM, Johnson MC. Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J Virol 2009, 83:4060-4067. 10.1128/JVI.02425-08, 2668502, 19224995.
5. Johnson MC. Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS Res Human Retroviruses 2011, 27:239-247.
6. Checkley MA, Luttge BG, Freed EO. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol 2011, 410:582-608. 10.1016/j.jmb.2011.04.042, 3139147, 21762802.
7. Boyko V, Leavitt M, Gorelick R, Fu W, Nikolaitchik O, Pathak VK, Nagashima K, Hu WS. Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens. Mol Cell 2006, 23:281-287. 10.1016/j.molcel.2006.05.028, 16857594.
8. Lucas TM, Lyddon TD, Grosse SA, Johnson MC. Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites. Virology 2010, 405:548-555. 10.1016/j.virol.2010.06.017, 2923235, 20655565.
9. Murakami T, Freed EO. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Nat Acad Sci USA 2000, 97:343-348. 10.1073/pnas.97.1.343, 26665, 10618420.
10. Wyma DJ, Kotov A, Aiken C. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J Virol 2000, 74:9381-9387. 10.1128/JVI.74.20.9381-9387.2000, 112366, 11000206.
11. Freed EO, Martin MA. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 1984-1989, 1995:69.
12. Mammano F, Kondo E, Sodroski J, Bukovsky A, Gottlinger HG. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol 1995, 69:3824-3830. 189100, 7745730.
13. Mammano F, Salvatori F, Indraccolo S, De Rossi A, Chieco-Bianchi L, Gottlinger HG. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J Virol 1997, 71:3341-3345. 191476, 9060707.
14. Schnierle BS, Stitz J, Bosch V, Nocken F, Merget-Millitzer H, Engelstadter M, Kurth R, Groner B, Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Nat Acad Sci USA 1997, 94:8640-8645. 10.1073/pnas.94.16.8640, 23056, 9238030.
15. Scholz I, Still A, Dhenub TC, Coday K, Webb M, Barklis E. Analysis of human immunodeficiency virus matrix domain replacements. Virology 2008, 371:322-335. 10.1016/j.virol.2007.10.010, 2708115, 17996264.
16. Gregory DA, Lyddon TD, Johnson MC. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions. J Virol 2013, 87:1518-1527. 10.1128/JVI.02604-12, 3554149, 23152533.
17. Wang CT, Zhang Y, McDermott J, Barklis E. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J Virol 1993, 67:7067-7076. 238168, 7693966.
18. Reil H, Bukovsky AA, Gelderblom HR, Gottlinger HG. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J 1998, 17:2699-2708. 10.1093/emboj/17.9.2699, 1170610, 9564051.
19. Checkley MA, Luttge BG, Mercredi PY, Kyere SK, Donlan J, Murakami T, Summers MF, Cocklin S, Freed EO. Reevaluation of the requirement for TIP47 in human immunodeficiency virus type 1 envelope glycoprotein incorporation. J Virol 2013, 87:3561-3570. 10.1128/JVI.03299-12, 3592152, 23325685.
20. Bauby H, Lopez-Verges S, Hoeffel G, Delcroix-Genete D, Janvier K, Mammano F, Hosmalin A, Berlioz-Torrent C. TIP47 is required for the production of infectious HIV-1 particles from primary macrophages. Traffic (Copenhagen, Denmark) 2010, 11:455-467.
21. Lopez-Verges S, Camus G, Blot G, Beauvoir R, Benarous R, Berlioz-Torrent C. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc Nat Acad Sci USA 2006, 103:14947-14952. 10.1073/pnas.0602941103, 1595456, 17003132.
22. Briggs JA, Wilk T, Fuller SD. Do lipid rafts mediate virus assembly and pseudotyping?. J Gen Virol 2003, 84:757-768. 10.1099/vir.0.18779-0, 12655075.
23. Pickl WF, Pimentel-Muinos FX, Seed B. Lipid rafts and pseudotyping. J Virol 2001, 75:7175-7183. 10.1128/JVI.75.15.7175-7183.2001, 114446, 11435598.
24. Chazal N, Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev 2003, 67:226-237. table of contents, 10.1128/MMBR.67.2.226-237.2003, 156468, 12794191.
25. Hogue IB, Grover JR, Soheilian F, Nagashima K, Ono A. Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. J Virol 2011, 85:9749-9766. 10.1128/JVI.00743-11, 3196429, 21813604.
26. Krementsov DN, Rassam P, Margeat E, Roy NH, Schneider-Schaulies J, Milhiet PE, Thali M. HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components. Traffic (Copenhagen, Denmark) 2010, 11:1401-1414.
27. Lorizate M, Sachsenheimer T, Glass B, Habermann A, Gerl MJ, Krausslich HG, Brugger B. Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines. Cell Microbiol 2013, 15:292-304. 10.1111/cmi.12101, 23279151.
28. Jolly C, Sattentau QJ. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J Virol 2007, 81:7873-7884. 10.1128/JVI.01845-06, 1951303, 17522207.
29. Leung K, Kim JO, Ganesh L, Kabat J, Schwartz O, Nabel GJ. HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions. Cell Host Microbe 2008, 3:285-292. 10.1016/j.chom.2008.04.004, 2998762, 18474355.
30. Roy NH, Chan J, Lambele M, Thali M. Clustering and mobility of HIV-1 Env at viral assembly sites predict its propensity to induce cell-cell fusion. J Virol 2013, 87:7516-7525. 10.1128/JVI.00790-13, 3700267, 23637402.
31. Muranyi W, Malkusch S, Muller B, Heilemann M, Krausslich HG. Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. PLoS Pathog 2013, 9:e1003198. 10.1371/journal.ppat.1003198, 3585150, 23468635.
32. Janaka SK, Gregory DA, Johnson MC. Retrovirus glycoprotein functionality requires proper alignment of the ectodomain and the membrane proximal cytoplasmic tail. J Virol 2013, 87(23):12805-12813. 10.1128/JVI.01847-13, 24049172.
33. Orentas RJ, Hildreth JE. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Human Retroviruses 1993, 9:1157-1165.
34. Brindley MA, Hughes L, Ruiz A, McCray PB, Sanchez A, Sanders DA, Maury W. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol 2007, 81:7702-7709. 10.1128/JVI.02433-06, 1933332, 17475648.
35. Sun X, Belouzard S, Whittaker GR. Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein. J Biol Chem 2008, 283:6418-6427. 10.1074/jbc.M708955200, 18165228.
36. Chan SY, Speck RF, Ma MC, Goldsmith MA. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 2000, 74:4933-4937. 10.1128/JVI.74.10.4933-4937.2000, 112022, 10775638.
37. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511. 10.1016/j.cell.2009.08.039, 2844890, 19879838.
38. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000, 74:3264-3272. 10.1128/JVI.74.7.3264-3272.2000, 111827, 10708443.
39. Muller B, Heilemann M. Shedding new light on viruses: super-resolution microscopy for studying human immunodeficiency virus. Trends in microbiology 2013, 21(10):522-533. 10.1016/j.tim.2013.06.010, 23916730.
40. Marschang P, Sodroski J, Wurzner R, Dierich MP. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur J Immunol 1995, 25:285-290. 10.1002/eji.1830250147, 7531147.
41. Saifuddin M, Hedayati T, Atkinson JP, Holguin MH, Parker CJ, Spear GT. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol 1997, 78(Pt 8):1907-1911.
42. Ivanchenko S, Godinez WJ, Lampe M, Krausslich HG, Eils R, Rohr K, Brauchle C, Muller B, Lamb DC. Dynamics of HIV-1 assembly and release. PLoS Pathog 2009, 5:e1000652. 10.1371/journal.ppat.1000652, 2766258, 19893629.
43. Henriksson P, Bosch V. Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner. Virology 1998, 251:16-21. 10.1006/viro.1998.9403, 9813198.
44. Meerloo T, Parmentier HK, Osterhaus AD, Goudsmit J, Schuurman HJ. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. AIDS 1992, 6:1105-1116. 10.1097/00002030-199210000-00007, 1466841.
45. Kothe DL, Decker JM, Li Y, Weng Z, Bibollet-Ruche F, Zammit KP, Salazar MG, Chen Y, Salazar-Gonzalez JF, Moldoveanu Z, Mestecky J, Gao F, Haynes BF, Shaw GM, Muldoon M, Korber BT, Hahn BH. Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Virology 2007, 360:218-234. 10.1016/j.virol.2006.10.017, 1945152, 17097711.
46. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, Cicchetti G, Allen PG, Pypaert M, Cunningham JM, Mothes W. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic (Copenhagen, Denmark) 2003, 4:785-801.
47. Perez LG, Davis GL, Hunter E. Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions. J Virol 1987, 61:2981-2988. 255870, 3041017.
48. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther 1999, 6:715-728. 10.1038/sj.gt.3300895, 10505094.
49. Sinn PL, Hickey MA, Staber PD, Dylla DE, Jeffers SA, Davidson BL, Sanders DA, McCray PB. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 2003, 77:5902-5910. 10.1128/JVI.77.10.5902-5910.2003, 154009, 12719583.
50. Ochsenbauer-Jambor C, Delos SE, Accavitti MA, White JM, Hunter E. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex. J Virol 2002, 76:7518-7527. 10.1128/JVI.76.15.7518-7527.2002, 136349, 12097564.